AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1.
Source: R/aet02.R
aet02.RdThe AET02 table provides an overview of the number of subjects experiencing adverse events and the number of advert
events categorized by Body System and Dictionary-Derived Term.
Usage
aet02_label
aet02_main(
adam_db,
arm_var = "ACTARM",
row_split_var = "AEBODSYS",
lbl_overall = NULL,
summary_labels = list(all = aet02_label, TOTAL = c(nonunique =
"Overall total number of events")),
...
)
aet02_pre(adam_db, row_split_var = "AEBODSYS", ...)
aet02_post(tlg, row_split_var = "AEBODSYS", prune_0 = TRUE, ...)
aet02Arguments
- adam_db
(
listofdata.frames) object containing theADaMdatasets- arm_var
(
string) variable used for column splitting- row_split_var
(
character) additional row split variables.- lbl_overall
(
string) label used for overall column, if set toNULLthe overall column is omitted- summary_labels
(
list) of summarize labels. See details.- ...
not used.
- tlg
(
TableTree,Listingorggplot) object typically produced by amainfunction.- prune_0
(
flag) remove 0 count rows
Value
the main function returns an rtables object.
the preprocessing function returns a list of data.frame.
the postprocessing function returns an rtables object or an ElementaryTable (null report).
Details
Numbers represent absolute numbers of subject and fraction of
N, or absolute number of event when specified.Remove zero-count rows unless overridden with
prune_0 = FALSE.Split columns by arm.
Does not include a total column by default.
Sort Dictionary-Derived Code (
AEDECOD) by highest overall frequencies.Missing values in
AEBODSYS, andAEDECODare labeled byNo Coding Available.summary_labelsis used to control the summary for each level. If "all" is used, then each split will have that summary statistic with the labels. One special case is "TOTAL", this is for the overall population.
Functions
aet02_label: Default labelsaet02_main(): Main TLG functionaet02_pre(): Preprocessingaet02_post(): Postprocessing
Examples
run(aet02, syn_data)
#> MedDRA System Organ Class A: Drug X B: Placebo C: Combination
#> MedDRA Preferred Term (N=15) (N=15) (N=15)
#> —————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one adverse event 13 (86.7%) 14 (93.3%) 15 (100%)
#> Overall total number of events 58 59 99
#> cl B.2
#> Total number of patients with at least one adverse event 11 (73.3%) 8 (53.3%) 10 (66.7%)
#> Total number of events 18 15 20
#> dcd B.2.2.3.1 8 (53.3%) 6 (40.0%) 7 (46.7%)
#> dcd B.2.1.2.1 5 (33.3%) 6 (40.0%) 5 (33.3%)
#> cl D.1
#> Total number of patients with at least one adverse event 9 (60.0%) 5 (33.3%) 11 (73.3%)
#> Total number of events 13 9 19
#> dcd D.1.1.1.1 4 (26.7%) 4 (26.7%) 7 (46.7%)
#> dcd D.1.1.4.2 6 (40.0%) 2 (13.3%) 7 (46.7%)
#> cl A.1
#> Total number of patients with at least one adverse event 7 (46.7%) 6 (40.0%) 10 (66.7%)
#> Total number of events 8 11 16
#> dcd A.1.1.1.2 5 (33.3%) 6 (40.0%) 6 (40.0%)
#> dcd A.1.1.1.1 3 (20.0%) 1 (6.7%) 6 (40.0%)
#> cl B.1
#> Total number of patients with at least one adverse event 5 (33.3%) 6 (40.0%) 8 (53.3%)
#> Total number of events 6 6 12
#> dcd B.1.1.1.1 5 (33.3%) 6 (40.0%) 8 (53.3%)
#> cl C.2
#> Total number of patients with at least one adverse event 6 (40.0%) 4 (26.7%) 8 (53.3%)
#> Total number of events 6 4 12
#> dcd C.2.1.2.1 6 (40.0%) 4 (26.7%) 8 (53.3%)
#> cl D.2
#> Total number of patients with at least one adverse event 2 (13.3%) 5 (33.3%) 7 (46.7%)
#> Total number of events 3 5 10
#> dcd D.2.1.5.3 2 (13.3%) 5 (33.3%) 7 (46.7%)
#> cl C.1
#> Total number of patients with at least one adverse event 4 (26.7%) 4 (26.7%) 5 (33.3%)
#> Total number of events 4 9 10
#> dcd C.1.1.1.3 4 (26.7%) 4 (26.7%) 5 (33.3%)